CHAN Kwan Yi Queeny - The Chinese University of Hong Kong
CHAN Kwan Yi Queeny - The Chinese University of Hong Kong
CHAN Kwan Yi Queeny - The Chinese University of Hong Kong
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Department <strong>of</strong> Clinical Oncology<br />
AZIM A Hatem and MOK Shu Kam Tony. "Systemic Nonhormonal Management <strong>of</strong> Advanced<br />
Prostate Cancer and Its Likely Impact on Patients’ Survival and Quality <strong>of</strong> Life". Anti-Cancer<br />
Drugs vol.19 no.6, pp.645-53. United Kingdom: Lippincott Williams & Wilkins, 2008.07.<br />
CUI Yan; YING <strong>Yi</strong>ng; VAN HASSELT Charles Andrew; NG Ka Man; YU Jun; ZHANG Qian;<br />
JIN Jie; LIU Dingxie; RHIM Johng S; RHA Sun Young; <strong>CHAN</strong> Anthony Tak Cheung;<br />
SRIVASTAVA Gopesh; LOYO Myriam; TAO George S W; SELLAR Grant C; SUNG Joseph<br />
Jao <strong>Yi</strong>u; SIDRANSKY David and TAO Qian. "OPCML Is a Broad Tumor Suppressor for Multiple<br />
Carcinomas and Lymphomas with Frequently Epigenetic Inactivation". PLoS ONE vol.3 no.8, e2990.<br />
United States <strong>of</strong> America: Public Library <strong>of</strong> Science, 2008.08.20.<br />
LOONG Herbert; MA Buig Yue Brigette and <strong>CHAN</strong> Anthony Tak Cheung. "Update on the<br />
management and therapeutic monitoring <strong>of</strong> advanced nasopharyngeal cancer". Hematology/oncology<br />
clinics <strong>of</strong> North America vol.22 no.6, pp.1267-78. United States <strong>of</strong> America: Elsevier Health<br />
Science, 2008.12.<br />
CUI Yan; YING <strong>Yi</strong>ng; NG Ka Man; <strong>CHAN</strong> Anthony Tak Cheung and TAO Qian. "OPCML Is<br />
a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic<br />
Inactivation. (Abstract)". Paper presented in the <strong>The</strong> 13th Biennial Conference <strong>of</strong> the International<br />
Association for Research on Epstein-Barr Virus and Associated Diseases, Nov 6-11, 2008,<br />
Guangzhou, China, 1 pgs. Guangzhou, China, 2008.11.06.<br />
KIM Edward; HIRSH Vera; MOK Shu Kam Tony; SOCINSKI Mark; WU <strong>Yi</strong>-long; LI<br />
Long-yun; WATKINS Claire; SELLERS Mark; LOWE Elizabeth; SUN Yan; LIAO Mei-lin;<br />
OSTERLIND Kell; RECK Martin; ARMOUR Alison; SHEPHERD Frances; LIPPMAN Scott<br />
and DOUILLARD Jean-yves. "Gefitinib Versus Docetaxel in Previously Treated Non-Small-Cell<br />
Lung Cancer (INTEREST): a Randomzed Phase III Trial". Lancet vol.372 no.9652, pp.1809-18.<br />
United Kingdom: Lancet Ltd, 2008.11.22.<br />
LUI Wai Yan Vivian. "Targeting Signal Transduction Pathways in Nasopharyngeal Cancer (NPC).<br />
(Abstract)". Paper presented in the <strong>The</strong> <strong>Chinese</strong> <strong>University</strong> <strong>of</strong> <strong>Hong</strong> <strong>Kong</strong>-M. D. Anderson Cancer<br />
Center Sister Institution Signing Ceremony, Mini-Symposium (July, 2008), <strong>The</strong> <strong>Chinese</strong> <strong>University</strong> <strong>of</strong><br />
<strong>Hong</strong> <strong>Kong</strong>, 2008, one pgs. <strong>Hong</strong> <strong>Kong</strong> SAR, 2008.07.<br />
KOPPIKAR Priya; LUI Wai Yan Vivian; MAN David; XI Sichuan; CHAI Raymond; NELSON<br />
Elizabeth; TOBEY Allison and GRANDIS Jennifer Rubin. "Constitutive activation <strong>of</strong> signal<br />
transducer and activator <strong>of</strong> transcription 5 contributes to tumor growth, epithelial-mesenchymal<br />
transition, and resistance to epidermal growth factor receptor targeting". Clinical cancer<br />
research vol.14 no.23, pp.7682-90. United States <strong>of</strong> America: <strong>The</strong> Association, 2008.12.01.<br />
Faculty <strong>of</strong> Medicine
Change language